Graig Suvannavejh, Biotech & Biopharma Analyst at Mizuho Securities, says biotech’s surge is driven by strong M&A, innovation ...

Metagenomi will cut 31 jobs and shift focus to its hemophilia A gene therapy as founding CEO Brian Thomas steps down and Jian ...

Dr. Richard Pazdur is “likely the best possible person for the role,” says one analyst. A calmer course for the FDA could add ...

The drug development funding playbook that worked for decades is now in trouble, University of Pennsylvania Perelman School ...

Jonathan Faison, leader of Seeking Alpha’s ROTY Biotech Community, shares how he uses the platform’s tools - from news, ...

Esperion faces pressure from emerging oral PCSK9i and CETP inhibitors, which offer superior LDL-c lowering. See why I rate ...

Metsera said it has struck a revised merger agreement with Pfizer that values the company at up to $86.25 per share in cash.

Lilly will also gain certain rights to MeiraGTx’s proprietary riboswitch technology for use in gene editing in the eye. Under ...

Now, let's delve into solving the Biotech crops crossword clue, featured as 49 Down in the USA Today Crossword on November 9, ...

Launched its first Asia office to support biotech and healthtech innovation and collaboration within the regionThe Asia ...

Celleo Biotech is using the PIPETBOY GENIUS serological pipet controller from INTEGRA Biosciences to streamline the ...